Target
Serine/threonine-protein kinase pim-1
Ligand
BDBM602103
Substrate
n/a
Meas. Tech.
Pim-1 Inhibitory Activity Assay
Ki
0.009±n/a nM
Citation
 Inoue, MOgoshi, YFurukawa, TMachida, TMitani, IHarada, KNakagawa, YYamaoka, N Tetrahydrobenzofurodiazepinone compound and pharmaceutical use thereof US Patent  US11643417 Publication Date 5/9/2023 
Target
Name:
Serine/threonine-protein kinase pim-1
Synonyms:
PIM-1 Kinase | PIM1 | PIM1_HUMAN | Proto-oncogene serine/threonine-protein kinase Pim-1 | Serine/threonine-protein kinase (PIM1) | Serine/threonine-protein kinase PIM | Serine/threonine-protein kinase PIM1 | Serine/threonine-protein kinase pim-1 (PIM1)
Type:
Protein
Mol. Mass.:
35681.82
Organism:
Homo sapiens (Human)
Description:
P11309
Residue:
313
Sequence:
MLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK
  
Inhibitor
Name:
BDBM602103
Synonyms:
US11643417, Ex. No. 116
Type:
Small organic molecule
Emp. Form.:
C23H27F3N2O4
Mol. Mass.:
452.4667
SMILES:
OCC1(O)CCC(CCN2CC3(CC3)NC(=O)c3oc4ccc(cc4c23)C(F)(F)F)CC1 |(7.29,1.28,;5.83,1.77,;4.67,.76,;6.13,.26,;3.51,-.25,;2.05,.25,;1.76,1.76,;.3,2.25,;-.86,1.24,;-2.32,1.74,;-2.5,3.27,;-3.81,4.08,;-3.19,5.48,;-4.72,5.32,;-5.26,3.56,;-5.76,2.1,;-7.29,1.92,;-4.93,.8,;-5.56,-.6,;-4.41,-1.63,;-4.41,-3.17,;-3.08,-3.94,;-1.74,-3.17,;-1.74,-1.63,;-3.08,-.86,;-3.4,.64,;-.41,-3.94,;.92,-3.17,;-.41,-5.48,;-.41,-2.4,;2.92,2.77,;4.37,2.27,)|
Structure:
Search PDB for entries with ligand similarity: